Post hoc analysis shows vutrisiran is effective and well tolerated in East Asian patients, indicating safety and efficacy.
Although the number of East Asian patients in HELIOS-A was small, this post hoc analysis showed similar outcomes to those in the overall study populations, indicating that vutrisiran is effective and well tolerated in East Asian patients.
No takes yet. Share an insight, caveat, or question.
Oh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: